Exhibit 4.1
NOTE AND WARRANT PURCHASE
AGREEMENT
Dated as of May 21,
2009
among
JUMA TECHNOLOGY
CORP.
and
THE PURCHASERS LISTED ON EXHIBIT
A
|
|
Page
|
|
ARTICLE
I Purchase and Sale of the Notes and
Warrants
|
|
|
Section
1.1
|
Purchase and
Sale of Notes
|
1
|
|
Section
1.2
|
Warrants
|
1
|
|
Section
1.3
|
Conversion
Shares
|
2
|
|
Section
1.4
|
Purchase Price
and Closing
|
2
|
|
|
|
|
|
ARTICLE
II Representations and Warranties
|
|
|
Section
2.1
|
Representations
and Warranties of the Company
|
2
|
|
Section
2.2
|
Representations
and Warranties of the Purchasers
|
13
|
|
|
|
|
ARTICLE
III Covenants
|
|
|
Section
3.1
|
Securities
Compliance
|
15
|
|
Section
3.2
|
Registration
and Listing
|
15
|
|
Section
3.3
|
Inspection
Rights
|
15
|
|
Section
3.4
|
Compliance with
Laws
|
16
|
|
Section
3.5
|
Keeping of
Records and Books of Account
|
16
|
|
Section
3.6
|
Furnishing of
Information
|
16
|
|
Section
3.7
|
Reporting
Requirements
|
16
|
|
Section
3.8
|
Amendments
|
16
|
|
Section
3.9
|
Other
Agreements
|
17
|
|
Section
3.10
|
Distributions
|
17
|
|
Section
3.11
|
Use of
Proceeds
|
17
|
|
Section
3.12
|
Reservation of
Shares
|
17
|
|
Section
3.13
|
Transfer Agent
Instructions
|
17
|
|
Section
3.14
|
Disposition of
Assets
|
18
|
|
Section
3.15
|
Reporting
Status
|
18
|
|
Section
3.16
|
Disclosure of
Transaction
|
18
|
|
Section
3.17
|
Disclosure of
Material Information
|
18
|
|
Section
3.18
|
Pledge of
Securities
|
18
|
|
Section
3.19
|
Form S-1
Eligibility
|
19
|
|
Section
3.20
|
DTC
|
19
|
|
Section
3.21
|
Issuance of
Variable Securities
|
19
|
|
Section
3.22
|
Approval of
Acquisitions.
|
19
|
|
Section
3.23
|
Most Favored
Nations
|
19
|
|
|
|
|
Section
4.1
|
Conditions
Precedent to the Obligation of the Company to Sell the
Shares
|
19
|
|
Section
4.2
|
Conditions
Precedent to the Obligation of the Purchasers to Purchase the
Shares
|
20
|
|
|
|
|
ARTICLE
V Stock Certificate Legend
|
|
|
Section
5.1
|
Legend
|
22
|
|
|
|
|
ARTICLE
VI Indemnification
|
|
|
Section
6.1
|
General
Indemnity
|
23
|
|
Section
6.2
|
Indemnification
Procedure
|
23
|
|
|
|
|
ARTICLE
VII Registration Rights
|
|
|
Section
7.1
|
Piggyback
Registration Rights
|
24
|
|
Section
7.2
|
Assignment of
Registration Rights
|
25
|
|
Section
7.3
|
Underwriter
Status
|
25
|
|
|
|
ARTICLE
VIII Miscellaneous
|
|
Section 8.1
|
Fees and
Expenses
|
25
|
|
Section
8.2
|
Specific
Enforcement
|
26
|
|
Section
8.3
|
Entire
Agreement; Amendment
|
26
|
|
Section
8.4
|
Rescission and
Withdrawal Right
|
26
|
|
Section
8.5
|
Notices
|
27
|
|
Section
8.6
|
Waivers
|
27
|
|
Section
8.7
|
Headings
|
27
|
|
Section
8.8
|
Successors and
Assigns
|
28
|
|
Section
8.9
|
No Third Party
Beneficiaries
|
28
|
|
Section
8.10
|
Governing Law;
Consent to Jurisdiction
|
28
|
|
Section
8.11
|
Survival
|
28
|
|
Section
8.12
|
Counterparts
|
28
|
|
Section
8.13
|
Publicity
|
28
|
|
Section
8.14
|
Severability
|
28
|
|
Section
8.15
|
Further
Assurances
|
29
|
|
EXHIBITS
|
|
|
|
Exhibit
A
|
List of
Purchasers
|
|
Exhibit
B
|
Form of 10%
Convertible Bridge Note
|
|
Exhibit
C
|
Series A
Warrant
|
|
Exhibit
D
|
Irrevocable
Transfer Agent Instructions
|
|
Exhibit
E
|
Opinion of
Counsel
|
NOTE AND WARRANT PURCHASE
AGREEMENT
This NOTE AND WARRANT PURCHASE AGREEMENT (this
“ Agreement ”) is dated as of May 21,
2009 by and among Juma Technology Corp., a Delaware corporation
(the “ Company ”), and each of the
Purchasers whose names are set forth on Exhibit A
hereto (individually, a “ Purchaser ” and
collectively, the “ Purchasers
”).
WHEREAS , the Purchasers hold 10% convertible bridge
notes dated February 9, 2009 in the outstanding principal amount of
$1,500,000 (the “ Existing Notes
”);
WHEREAS , the investment by the Purchasers pursuant to
this Agreement constitutes a Qualified Financing as defined in the
Existing Notes; and
WHEREAS , pursuant to the Existing Notes, the Purchasers
desire to surrender their Existing Notes for cancellation in
exchange for the issuance by the Company to the Purchasers of Notes
(as such term is defined in Section 1.1 ) in
accordance with the terms and conditions set forth in this
Agreement and in the amounts listed on Exhibit A
hereto.
NOW, THEREFORE , in consideration of the covenants, promises
and representations set forth herein, and for other good and
valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties agree as follows:
ARTICLE I
Purchase and Sale of Notes and
Warrants
Section 1.1 Purchase and
Sale of Notes . Upon the following terms and conditions, (a)
the Company and one of its subsidiaries, Nectar Services Corp., a
Delaware Corporation (“ Nectar ” and
together with the Company, the “ Issuers
”) shall jointly issue and sell to the Purchasers and each of
the Purchasers shall purchase from the Company, 10% convertible
bridge notes in the aggregate principal amount of three million
dollars ($3,000,000) and (b) the Purchasers shall surrender for
cancellation the Existing Notes in exchange for 10% convertible
bridge notes in the aggregate principal amount of one million five
hundred forty two thousand five hundred dollars ($1,542,500) (the
notes referred to in the foregoing clauses (a) and (b), the “
Notes ”). The Notes provide for (i) optional
conversion into shares of the Company’s common stock, par
value $0.0001 per share (the “ Common Stock
”) and (ii) mandatory conversion upon the occurrence of a
Qualified Financing (as defined in the Notes). The Notes shall be
substantially in the form attached hereto as Exhibit
B . The Company and the Purchasers are executing
and delivering this Agreement in accordance with and in reliance
upon the exemption from securities registration afforded by Rule
506 of Regulation D (“ Regulation D ”) as
promulgated by the United States Securities and Exchange Commission
(the “ Commission ”) under the Securities
Act of 1933, as amended (the “ Securities Act
”) or Section 4(2) of the Securities Act.
Section
1.2
Warrants . Upon the following terms and conditions and for
no additional consideration, each of the Purchasers shall be issued
Series A Warrants, in substantially the form attached hereto as
Exhibit C (the “ Series A
Warrants ” and/or the “ Warrants
”) to purchase up to fifty percent (50%) of that number of
shares of the Company’s Common Stock into which the Note
issued to the applicable Purchaser originally
converts. Any shares of Common Stock issuable upon
exercise of the Warrants (and such shares when issued) are herein
referred to as the “ Warrant Shares .”
The Warrants shall expire five (5) years following the Closing Date
and shall have an initial exercise price equal to fifteen cents
($0.15) per share.
Section 1.3
Conversion Shares . The Company has authorized and will
reserve and covenants to continue to reserve, free of preemptive
rights and other similar contractual rights of stockholders, (i)
such number of shares of Common Stock equal to one hundred
twenty percent (120%) of the number of shares of Common Stock as
shall from time to time be sufficient to effect an Optional
Conversion (as defined in the Notes) of all of the Notes, and
(ii) as of the date hereof, such number of shares of Common Stock
equal to one hundred twenty percent (120%) of the number of shares
of Common Stock as shall from time to time be sufficient to effect
the exercise of the Warrants then outstanding. Any shares of Common
Stock issuable upon a conversion of the Note (and such shares when
issued) are herein referred to as the “ Conversion
Shares .” The Notes, the Warrants, the Conversion
Shares and the Warrant Shares are sometimes collectively referred
to as the “ Securities .”
Section 1.4
Purchase Price and Closing . Subject to the terms and
conditions hereof, the Issuers agree to issue and sell to the
Purchasers and, in consideration of and in express reliance upon
the representations, warranties, covenants, terms and conditions of
this Agreement, the Purchasers, severally but not jointly, agree to
purchase the Notes and the Warrants for an aggregate purchase price
of three million dollars ($3,000,000) (the “
Purchase Price ”) and the cancellation of the
Existing Notes. The closing under this Agreement (the “
Closing ”) shall take place on or about May 21,
2009 (the “ Closing Date
”). The Closing under this Agreement shall take
place at the offices of Sadis & Goldberg LLP, 551 Fifth Avenue,
21 st
Floor, New York, New York 10176 at
10:00 a.m., New York time; provided , that all of the
conditions set forth in Article IV hereof and
applicable to the Closing shall have been fulfilled or waived in
accordance herewith. Subject to the terms and conditions
of this Agreement, at the Closing the Company shall deliver or
cause to be delivered to each Purchaser (x) its Notes for the
principal amount set forth opposite the name of such Purchaser on
Exhibit A hereto, (y) its Warrants to purchase such
number of shares of Common Stock as is set forth opposite the name
of such Purchaser on Exhibit A attached
hereto and (z) any other documents required to be delivered
pursuant to Article IV hereof. At the Closing, each
Purchaser shall deliver the applicable Purchase Price by wire
transfer to the Company and surrender of the applicable Existing
Notes to the Company. In addition, the parties
acknowledge that no more than twenty-five thousand ($25,000)
dollars of the Purchase Price funded on the Closing Date shall be
deducted by the Purchase Price from the total amount otherwise
payable to the Company, and paid over to counsel for the Purchasers
in payment of reasonable legal fees and out of pocket expenses of
the Purchasers’ counsel.
ARTICLE II
Representations and
Warranties
Section 2.1
Representations and Warranties of the Company . Each of
the Issuers hereby represents and warrants to the Purchasers, as of
the date hereof and as of the Closing Date (except as set forth on
the Schedule of Exceptions attached hereto with each numbered
Schedule corresponding to the section number herein), as follows
(unless otherwise specifically stated herein this Section
2.1 to the contrary, all references to the Company shall be
deemed to refer collectively to the Issuers):
(a)
Organization, Good Standing and Power . The Company is a
corporation duly incorporated, validly existing and in good
standing under the laws of the State of Delaware and has the
requisite corporate power to own, lease and operate its properties
and assets and to conduct its business as it is now being
conducted. Nectar is a corporation duly incorporated, validly
existing and in good standing under the laws of the State of
Delaware and has the requisite corporate power to own, lease and
operate its properties and assets and to conduct its business as it
is now being conducted. Except as set forth in Schedule
2.1(g) hereto, the Company does not have any Subsidiaries.
Except as set forth on Schedule 2.1(a) , each of the
Company and each such Subsidiary is duly qualified as a foreign
corporation to do business and is in good standing in every
jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary except for
any jurisdiction(s) (alone or in the aggregate) in which the
failure to be so qualified will not have a Material Adverse Effect
(as defined in Section 2.1(c) hereof) on the
Company’s financial condition.
(b)
Authorization; Enforcement . The Company has the requisite
corporate power and authority to enter into and perform this
Agreement, the Notes, the Warrants and the Irrevocable
Transfer Agent Instructions (as defined in Section
3.13 ) substantially in the form of Exhibit
D attached hereto (collectively, the “
Transaction Documents ”) and to issue and sell
the Securities in accordance with the terms hereof. The execution,
delivery and performance of the Transaction Documents by the
Company and the consummation by it of the transactions contemplated
hereby and thereby have been duly and validly authorized by all
necessary corporate action, and except as set forth on
Schedule 2.1(b) , no further consent or authorization
of the Company or its board of directors or stockholders is
required. This Agreement has been duly executed and delivered by
the Company. The other Transaction Documents will have been duly
executed and delivered by the Company at the Closing. Each of the
Transaction Documents constitutes, or shall constitute when
executed and delivered, a valid and binding obligation of the
Company enforceable against the Company in accordance with its
terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation,
conservatorship, receivership or similar laws relating to, or
affecting generally the enforcement of, creditor’s rights and
remedies or by other equitable principles of general
application.
(c)
Capitalization . The authorized capital stock of the Company
and the shares thereof currently issued and outstanding as of the
date hereof are set forth on Schedule 2.1(c) hereto.
All of the outstanding shares of capital stock have been duly and
validly authorized and issued in compliance with all securities
laws. Except as set forth on Schedule 2.1(c)
hereto, no shares of Common Stock are entitled to preemptive rights
or registration rights and there are no outstanding options,
warrants, scrip, rights to subscribe to, call or commitments of any
character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company. There
are no contracts, commitments, understandings, or arrangements by
which the Company is or may become bound to issue additional shares
of the capital stock of the Company or options, securities or
rights convertible into shares of capital stock of the Company.
Except as set forth on Schedule 2.1(c) hereto, the
Company is not a party to any agreement granting registration or
anti-dilution rights to any person with respect to any of its
equity or debt securities. The Company is not a party to, and it
has no knowledge of, any agreement restricting the voting or
transfer of any shares of the capital stock of the Company. The
offer and sale of all capital stock, convertible securities,
rights, warrants, or options of the Company issued prior to the
Closing complied with all applicable Federal and state securities
laws, and no stockholder has a right of rescission or claim for
damages with respect thereto. The Company has furnished or made
available to the Purchasers true and correct copies of the
Company’s Certificate of Incorporation as in effect on the
date hereof (the “ Certificate
”) and the Company’s Bylaws as in effect on the
date hereof (the “ Bylaws ”). For the
purposes of this Agreement, “ Material Adverse
Effect ” means any material adverse effect on the
business, operations, properties, prospects, or financial condition
of the Company and its Subsidiaries, taken as a whole, and/or any
condition, circumstance, or situation that would prohibit or
otherwise materially interfere with the ability of the Company to
perform any of its obligations under this Agreement.
(d) Issuance of
Securities . The Notes and the Warrants to be issued at the
Closing have been duly authorized by all necessary corporate action
and when paid for or issued in accordance with the terms hereof,
the Notes and Warrants shall be validly issued and outstanding,
free and clear of all liens, encumbrances and rights of refusal of
any kind. When the Conversion Shares and the Warrant
Shares are issued in accordance with the terms of this Agreement,
the Notes and the Warrants, such shares will be duly authorized by
all necessary corporate action and validly issued and outstanding,
fully paid and nonassessable, free and clear of all liens,
encumbrances and rights of refusal of any kind and the holders
shall be entitled to all rights accorded to a holder of Common
Stock.
(e) No
Conflicts . The execution, delivery and performance of the
Transaction Documents by the Company, the performance by the
Company of its obligations under the Notes and/or the Warrants and
the consummation by the Company of the transactions contemplated
herein and therein do not and will not (i) violate any provision of
the Company’s Certificate or Bylaws, (ii) conflict with, or
constitute a default (or an event which with notice or lapse of
time or both would become a default) under, or give to others any
rights of termination, amendment, acceleration or cancellation of,
any agreement, mortgage, deed of trust, indenture, note, bond,
license, lease agreement, instrument or obligation to which the
Company is a party or by which it or its properties or assets are
bound, except for conflicts or defaults, which singularly or in the
aggregate do not and will not have a Material Adverse Effect, (iii)
create or impose a lien, mortgage, security interest, charge or
encumbrance of any nature on any property of the Company under any
agreement or any commitment to which the Company is a party or by
which the Company is bound or by which any of its respective
properties or assets are bound, except for liens, mortgages,
security interests, charges or encumbrances which singularly or in
the aggregate do not and will not have a Material Adverse Effect,
or (iv) result in a violation of any federal, state, local or
foreign statute, rule, regulation, order, judgment or decree
(including Federal and state securities laws and regulations)
applicable to the Company or any of its Subsidiaries or by which
any property or asset of the Company or any of its Subsidiaries are
bound or affected, except for violations, which singularly or
in the aggregate, do not and will not have a Material Adverse
Effect. The business of the Company and its Subsidiaries is not
being conducted in violation of any laws, ordinances or regulations
of any governmental entity, except for possible violations which
singularly or in the aggregate do not and will not have a Material
Adverse Effect. The Company is not required under Federal, state or
local law, rule or regulation to obtain any consent, authorization
or order of, or make any filing or registration with, any court or
governmental agency in order for it to execute, deliver or perform
any of its obligations under the Transaction Documents, or issue
and sell the Notes, the Warrants, the Conversion Shares and the
Warrant Shares in accordance with the terms hereof or thereof
(other than (x) any consent, authorization or order that has been
obtained as of the date hereof, (y) any filing or registration that
has been made as of the date hereof or (z) any filings which may be
required to be made by the Company with the Commission or state
securities administrators subsequent to the Closing, any
registration statement which may be filed pursuant hereto or any
other Transaction Document); provided , that for purposes of
the representation made in this sentence, the Company is assuming
and relying upon the accuracy of the relevant representations and
agreements of the Purchasers herein.
(f)
Commission Documents, Financial Statements . The Company has
timely filed all reports, schedules, forms, statements and other
documents required to be filed by it with the Commission pursuant
to the reporting requirements of the Securities Exchange Act of
1934, as amended the (“ Exchange Act ”),
including material filed pursuant to Section 13(a) or 15(d) of the
Exchange Act (all of the foregoing including filings incorporated
by reference therein being referred to herein as the “
Commission Documents ”). The Company has
delivered or made available via EDGAR or another Internet web-site
to each of the Purchasers true and complete copies of the
Commission Documents. Except for any information provided to Robert
Thomson, the Company has not provided to the Purchasers any
material non-public information or other information which,
according to applicable law, rule or regulation, was required to
have been disclosed publicly by the Company but which has not been
so disclosed, other than with respect to the transactions
contemplated by this Agreement. At the times of their respective
filings, the Commission Documents complied in all material respects
with the requirements of the Exchange Act and the rules and
regulations of the Commission promulgated thereunder and other
federal, state and local laws, rules and regulations applicable to
such documents, and, as of their respective dates, none of the
Commission Documents contained any untrue statement of a material
fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not
misleading. The financial statements of the Company included in the
Commission Documents comply as to form in all material respects
with applicable accounting requirements and the published rules and
regulations of the Commission or other applicable rules and
regulations with respect thereto. Such financial statements have
been prepared in accordance with U.S. generally accepted accounting
principles (“ GAAP ”) applied on a
consistent basis during the periods involved (except (i) as may be
otherwise indicated in such financial statements or the notes
thereto or (ii) in the case of unaudited interim statements, to the
extent they may not include footnotes or may be condensed or
summary statements), and fairly present in all material respects
the financial position of the Company and its Subsidiaries as of
the dates thereof and the results of operations and cash flows for
the periods then ended (subject, in the case of unaudited
statements, to normal year-end audit adjustments).
(g)
Subsidiaries . Schedule 2.1(g) hereto sets
forth each Subsidiary of the Company, showing the jurisdiction of
its incorporation or organization and showing the percentage of
each person’s ownership. Each Subsidiary is a corporation
duly incorporated, validly existing and in good standing under the
laws of its state of incorporation and has the requisite corporate
power to own, lease and operate its properties and assets and to
conduct its business as it is now being conducted. For the purposes
of this Agreement, “ Subsidiary ” shall
mean any corporation or other entity of which at least a majority
of the securities or other ownership interest having ordinary
voting power (absolutely or contingently) for the election of
directors or other persons performing similar functions are at the
time owned directly or indirectly by the Company and/or any of its
other Subsidiaries. All of the outstanding shares of capital stock
of each Subsidiary have been duly authorized and validly issued,
and are fully paid and nonassessable. There are no outstanding
preemptive, conversion or other rights, options, warrants or
agreements granted or issued by or binding upon any Subsidiary for
the purchase or acquisition of any shares of capital stock of any
Subsidiary or any other securities convertible into, exchangeable
for or evidencing the rights to subscribe for any shares of such
capital stock. Neither the Company nor any Subsidiary is subject to
any obligation (contingent or otherwise) to repurchase or otherwise
acquire or retire any shares of the capital stock of any Subsidiary
or any convertible securities, rights, warrants or options of the
type described in the preceding sentence. Neither the Company nor
any Subsidiary is party to, nor has any knowledge of, any agreement
restricting the voting or transfer of any shares of the capital
stock of any Subsidiary.
(h) No Material
Adverse Change . Other than as disclosed in the Company’s
Commission Documents, since December 31, 2008 the Company has not
experienced or suffered any Material Adverse Effect.
(i) No
Undisclosed Liabilities . Except as set forth on Schedule
2.1(i) , since December 31, 2008 neither the Company nor
any of its Subsidiaries has any liabilities, obligations, claims or
losses (whether liquidated or unliquidated, secured or unsecured,
absolute, accrued, contingent or otherwise) other than those
incurred in the ordinary course of the Company’s or its
Subsidiaries’ respective businesses and which, individually
or in the aggregate, do not or would not have a Material Adverse
Effect on the Company or its Subsidiaries, as the case may
be.
(j) Off Balance
Sheet Arrangements . There is no transaction,
arrangement, or other relationship between the Company and an
unconsolidated or other off balance sheet entity that is required
to be disclosed by the Company in its Commission Documents and is
not so disclosed or that otherwise would be reasonably likely to
have a Material Adverse Effect.
(k) No
Undisclosed Events or Circumstances . No event or circumstance
has occurred or exists with respect to the Company or its
Subsidiaries or their respective businesses, properties, prospects,
operations or financial condition, which, under applicable law,
rule or regulation, requires public disclosure or announcement by
the Company but which has not been so publicly announced or
disclosed.
(l)
Indebtedness . Schedule 2.1(l) hereto sets
forth as of the date hereof all outstanding secured and unsecured
Indebtedness of the Company or any Subsidiary, or for which the
Company or any Subsidiary has commitments. For the purposes of this
Agreement, “ Indebtedness ” shall mean
(a) any liabilities for borrowed money or amounts owed, whether
individually or in aggregate, in excess of $100,000 (other than
trade accounts payable incurred in the ordinary course of
business), (b) all guaranties, endorsements and other contingent
obligations in respect of Indebtedness of others, whether or not
the same are or should be reflected in the Company’s balance
sheet (or the notes thereto), except guaranties by endorsement of
negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (c) the
present value of any lease payments in excess of $25,000 due under
leases required to be capitalized in accordance with GAAP. Except
as set forth on Schedule 2.1(l) , neither the Company
nor any Subsidiary is in default with respect to any
Indebtedness.
(m) Title to
Assets . Except as set forth on Schedule 2.1(m) ,
each of the Company and the Subsidiaries has good and marketable
title to all of its real and personal property, free and clear of
any mortgages, pledges, charges, liens, security interests or other
encumbrances. Except as set forth on Schedule 2.1(m)
, all leases of the Company and each of its Subsidiaries are valid
and subsisting and in full force and effect.
(n)
Insurance . The Company and the Subsidiaries are insured by
insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the
businesses and location in which the Company and the Subsidiaries
are engaged. Neither the Company nor any Subsidiary has any
knowledge that it will be unable to renew its existing insurance
coverage for the Company and the Subsidiaries as and when such
coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a
significant increase in cost.
(o) Actions
Pending . There is no action, suit, claim, investigation,
arbitration, alternate dispute resolution proceeding or any other
proceeding pending or, to the knowledge of the Company, threatened
against the Company or any Subsidiary which questions the validity
of this Agreement or any of the other Transaction Documents or the
transactions contemplated hereby or thereby or any action taken or
to be taken pursuant hereto or thereto. There is no action, suit,
claim, investigation, arbitration, alternate dispute resolution
proceeding or any other proceeding pending or, to the knowledge of
the Company, threatened, against or involving the Company, any
Subsidiary or any of their respective properties or assets. There
are no outstanding orders, judgments, injunctions, awards or
decrees of any court, arbitrator or governmental or regulatory body
against the Company or any Subsidiary or any officers or directors
of the Company or Subsidiary in their capacities as
such.
(p) Compliance
with Law . The business of the Company and the Subsidiaries has
been and is presently being conducted in accordance with all
applicable federal, state and local governmental laws, rules,
regulations and ordinances, except for such noncompliance that,
individually or in the aggregate, would not cause a Material
Adverse Effect. The Company and each of its Subsidiaries have all
franchises, permits, licenses, consents and other governmental or
regulatory authorizations and approvals necessary for the conduct
of its business as now being conducted by it unless the failure to
possess such franchises, permits, licenses, consents and other
governmental or regulatory authorizations and approvals,
individually or in the aggregate, would not have a Material Adverse
Effect.
(q) Taxes .
The Company and each of the Subsidiaries has accurately prepared
and filed all federal, state and other tax returns required by law
to be filed by it, has paid or made provisions for the payment of
all taxes shown to be due and all additional assessments, and
adequate provisions have been and are reflected in the financial
statements of the Company and the Subsidiaries for all current
taxes and other charges to which the Company or any Subsidiary is
subject and which are not currently due and payable. None of the
federal income tax returns of the Company or any Subsidiary have
been audited by the Internal Revenue Service. The Company has no
knowledge of any additional assessments, adjustments or contingent
tax liability (whether federal or state) of any nature whatsoever,
whether pending or threatened against the Company or any Subsidiary
for any period, nor of any basis for any such assessment,
adjustment or contingency.
(r)
Certain Fees . No brokers, finders or financial advisory
fees or commissions will be payable by the Company or any
Subsidiary or any Purchaser with respect to the transactions
contemplated by this Agreement.
(s)
Disclosure . Neither this Agreement or the Schedules hereto
nor any other documents, certificates or instruments furnished to
the Purchasers by or on behalf of the Company or any Subsidiary in
connection with the transactions contemplated by this Agreement
contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements made herein
or therein, in the light of the circumstances under which they were
made herein or therein, not misleading.
(t)
Operation of Business . Except as set forth in
Schedule 2.1(t) , the Company and each of the
Subsidiaries owns or possesses all patents, trademarks, domain
names (whether or not registered) and any patentable improvements
or copyrightable derivative works thereof, websites and
intellectual property rights relating thereto, service marks, trade
names, copyrights, licenses and authorizations, and all rights with
respect to the foregoing, which are necessary for the conduct of
its business as now conducted without any conflict with the rights
of others.
(u)
Environmental Compliance . The Company and each of its
Subsidiaries have obtained all material approvals, authorization,
certificates, consents, licenses, orders and permits or other
similar authorizations of all governmental authorities, or from any
other person, that are required under any Environmental Laws.
Except as set forth on Schedule 2.1(u) , the
Commission Documents describe all material permits, licenses
and other authorizations issued under any Environmental Laws to the
Company or its Subsidiaries. “ Environmental
Laws ” shall mean all applicable laws relating to the
protection of the environment including, without limitation, all
requirements pertaining to reporting, licensing, permitting,
controlling, investigating or remediating emissions, discharges,
releases or threatened releases of hazardous substances, chemical
substances, pollutants, contaminants or toxic substances, materials
or wastes, whether solid, liquid or gaseous in nature, into the
air, surface water, groundwater or land, or relating to the
manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of hazardous substances, chemical
substances, pollutants, contaminants or toxic substances, material
or wastes, whether solid, liquid or gaseous in nature. The Company
has all necessary governmental approvals required under all
Environmental Laws and used in its business or in the business of
any of its Subsidiaries. The Company and each of its Subsidiaries
are also in compliance with all other limitations, restrictions,
conditions, standards, requirements, schedules and timetables
required or imposed under all Environmental Laws. Except for such
instances as would not individually or in the aggregate have a
Material Adverse Effect, there are no past or present events,
conditions, circumstances, incidents, actions or omissions relating
to or in any way affecting the Company or its Subsidiaries that
violate or may violate any Environmental Law after the Closing Date
or that may give rise to any environmental liability, or otherwise
form the basis of any claim, action, demand, suit, proceeding,
hearing, study or investigation (i) under any Environmental Law, or
(ii) based on or related to the manufacture, processing,
distribution, use, treatment, storage (including without limitation
underground storage tanks), disposal, transport or handling, or the
emission, discharge, release or threatened release of any hazardous
substance.
(v) Books and
Record Internal Accounting Controls . The books and records of
the Company and its Subsidiaries accurately reflect in all material
respects the information relating to the business of the Company
and the Subsidiaries, the location and collection of their assets,
and the nature of all transactions giving rise to the obligations
or accounts receivable of the Company or any Subsidiary. The
Company and each of its Subsidiaries maintain a system of internal
accounting controls sufficient, in the judgment of the Company, to
provide reasonable assurance that (i) transactions are executed in
accordance with management’s general or specific
authorizations, (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP
and to maintain asset accountability, (iii) access to assets is
permitted only in accordance with management’s general or
specific authorization and (iv) the recorded accountability for
assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any
differences.
(w) Material
Agreements . Except for the Transaction Documents (with respect
to clause (i) only), as disclosed in the Commission Documents or as
set forth on Schedule 2.1(w) hereto, or as would not
be reasonably likely to have a Material Adverse Effect, (i) the
Company and each of its Subsidiaries have performed all obligations
required to be performed by them to date under any written or oral
contract, instrument, agreement, commitment, obligation, plan or
arrangement, filed or required to be filed with the Commission (the
“ Material Agreements ”), (ii) neither
the Company nor any of its Subsidiaries has received any notice of
default under any Material Agreement and, (iii) to the best of the
Company’s knowledge, neither the Company nor any of its
Subsidiaries is in default under any Material Agreement now in
effect.
(x)
Intellectual Property . The Company and its
Subsidiaries own, or have rights to use, all inventions, know-how,
patents, patent applications, trademarks, trademark applications,
service marks, trade names, copyrights, licenses, trade secrets and
other similar rights that are necessary or material for use in
connection with their respective businesses now operated by them
and presently contemplated to be operated by them which the failure
to so have would have or reasonably be expected to result in a
Material Adverse Effect (collectively, the “
Intellectual Property Rights
”). None of the Company’s or any
Subsidiary’s Intellectual Property Rights have expired or
terminated, or are expected to expire or terminate, within three
years from the date of this Agreement. None of the
Company’s nor any Subsidiary has received written notice that
the Intellectual Property Rights used by the Company or any
Subsidiary violates or infringes upon the rights of any Person (as
defined below). To the knowledge of the Company, the
Company and its Subsidiaries’ patents and other Intellectual
Property Rights and the present activities of the Company and its
Subsidiaries do not infringe any patent, copyright, trademark,
trade name or other proprietary rights of any third party, and
there is no claim, action or proceeding being made or brought
against, or to the Company’s knowledge, being threatened
against, the Company or any Subsidiary regarding any of the
Intellectual Property Rights. The Company does not have
any knowledge of an infringement by another Person of any of the
Intellectual Property Rights by third parties and has no reason to
believe that any of its Intellectual Property Rights is
unenforceable. The Company has taken commercially
reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties.
“ Person ” means an individual or a
corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock
company, government (or an agency or political subdivision thereof)
or other entity of any kind.
(y)
Transactions with Affiliates . Except as set forth in the
Commission Documents, there are no loans, leases, agreements,
contracts, royalty agreements, management contracts or arrangements
or other continuing transactions between (a) the Company or any
Subsidiary on the one hand, and (b) on the other hand, any officer,
employee, consultant or director of the Company or any of its
Subsidiaries, or any person owning any capital stock of the Company
or any Subsidiary or any member of the immediate family of such
officer, employee, consultant, director or stockholder, or any
corporation or other entity controlled by such officer, employee,
consultant, director or stockholder, or a member of the immediate
family of such officer, employee, consultant, director or
stockholder.
(z)
Sarbanes-Oxley; Disclosure Controls . The Company is in
compliance in all material respects with all of the provisions of
the Sarbanes-Oxley Act of 2002 which are applicable to it as of the
Closing Date. The Company has established disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the Company and designed such disclosure controls
and procedures to ensure that material information relating to the
Company is made known to the certifying officers by others within
those entities, particularly during the period in which the
Company’s most recently filed periodic report under the
Exchange Act is being prepared. The Company’s certifying
officers have evaluated the effectiveness of the Company’s
disclosure controls and procedures as of the end of the most recent
periodic reporting period under the Exchange Act (such date, the
“ Evaluation Date ”). The Company
presented in its most recently filed periodic report under the
Exchange Act the conclusions of the certifying officers about the
effectiveness of the disclosure controls and procedures based on
their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no significant changes in the Company’s
internal controls over financial reporting (as such term is defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) or, to the
Company’s knowledge, in other factors that could reasonably
be expected to materially affect the Company’s internal
controls over financial reporting
(aa) Securities Act
of 1933 . Based in material part upon the representations
herein of the Purchasers, the Company has complied and will comply
with all applicable federal and state securities laws in connection
with the offer, issuance and sale of the Securities hereunder.
Neither the Company nor anyone acting on its behalf, directly or
indirectly, has or will sell, offer to sell or solicit offers to
buy any of the Securities or similar securities to, or solicit
offers with respect thereto from, or enter into any preliminary
conversations or negotiations relating thereto with, any person, or
has taken or will take any action so as to bring the issuance and
sale of any of the Securities under the registration provisions of
the Securities Act and applicable state securities laws, and
neither the Company nor any of its affiliates, nor any person
acting on its or their behalf, has engaged in any form of general
solicitation or general advertising (within the meaning of
Regulation D under the Securities Act) in connection with the offer
or sale of any of the Securities.
(bb) Governmental
Approvals . Except for the filing of any notice prior or
subsequent to the Closing Date that may be required under
applicable state and/or Federal securities laws (which if required,
shall be filed on a timely basis), including the filing of a Form D
and a registration statement or statements pursuant to
Section 7.1 herein, no authorization, consent,
approval, license, exemption of, filing or registration with any
court or governmental department, commission, board, bureau, agency
or instrumentality, domestic or foreign, is or will be necessary
for, or in connection with, the execution or delivery of the Notes
and the Warrants, or for the performance by the Company of its
obligations under the Transaction Documents.
(cc) Employees .
Neither the Company nor any Subsidiary has any collective
bargaining arrangements or agreements covering any of its
employees. Except as set forth on Schedule 2.1(cc) ,
neither the Company nor any Subsidiary has any employment contract,
agreement, regarding proprietary information, non-competition
agreement, non-solicitation agreement, confidentiality agreement,
or any other similar contract or restrictive covenant, relating to
the right of any officer, employee or consultant to be employed or
engaged by the Company or such Subsidiary. No officer, consultant
or key employee of the Company or any Subsidiary whose termination,
either individually or in the aggregate, could have a Material
Adverse Effect, has terminated or, to the knowledge of the Company,
has any present intention of terminating his or her employment or
engagement with the Company or any Subsidiary.
(dd) Absence of Certain
Developments . Except as set forth on Schedule
2.1(dd) , since December 31, 2008, neither the Company nor
any Subsidiary has:
(i) issued
any stock, bonds or other corporate securities or any rights,
options or warrants with respect thereto;
(ii) borrowed
any amount or incurred or become subject to any liabilities
(absolute or contingent) except current liabilities incurred in the
ordinary course of business which are comparable in nature and
amount to the current liabilities incurred in the ordinary course
of business during the comparable portion of its prior fiscal
year;
(iii) discharged
or satisfied any lien or encumbrance or paid any obligation or
liability (absolute or contingent), other than current liabilities
paid in the ordinary course of business;
(iv) declared
or made any payment or distribution of cash or other property to
stockholders with respect to its stock, or purchased or redeemed,
or made any agreements so to purchase or redeem, any shares of its
capital stock;
(v) sold,
assigned or transferred any other tangible assets, or canceled any
debts or claims, except in the ordinary course of
business;
(vi) sold,
assigned or transferred any patent rights, trademarks, trade names,
copyrights, trade secrets or other intangible assets or
intellectual property rights, or disclosed any proprietary
confidential information to any person except to customers in the
ordinary course of business;
(vii) suffered
any substantial losses or waived any rights of material value,
whether or not in the ordinary course of business, or suffered the
loss of any material amount of prospective business;
(viii) made
any changes in employee compensation except in the ordinary course
of business and consistent with past practices;
(ix) made
capital expenditures or commitments therefor that aggregate in
excess of $100,000;
(x) entered
into any other transaction other than in the ordinary course of
business, or entered into any other material transaction, whether
or not in the ordinary course of business;
(xi) made
charitable contributions or pledges in excess of
$25,000;
(xii) suffered
any material damage, destruction or casualty loss, whether or not
covered by insurance;
(xiii) experienced
any material problems with labor or management in connection with
the terms and conditions of their employment;
(xiv) effected
any two or more events of the foregoing kind which in the aggregate
would be material to the Company or its Subsidiaries; or
(xv) entered
into an agreement, written or otherwise, to take any of the
foregoing actions.
(ee) Public Utility Holding
Company Act and Investment Company Act Status . The Company is
not a “holding company” or a “public utility
company” as such terms are defined in the Public Utility
Holding Company Act of 1935, as amended. The Company is not, and as
a result of and immediately upon the Closing will not be, an
“investment company” or a company
“controlled” by an “investment company,”
within the meaning of the Investment Company Act of 1940, as
amended.
(ff) ERISA
. No liability to the Pension Benefit Guaranty Corporation has been
incurred with respect to any Plan (as defined below) by the Company
or any of its Subsidiaries which is or would be materially adverse
to the Company and its Subsidiaries. The execution and delivery of
this Agreement and the issuance and sale of the Securities will not
involve any transaction which is subject to the prohibitions of
Section 406 of ERISA or in connection with which a tax could be
imposed pursuant to Section 4975 of the Internal Revenue Code of
1986, as amended (the “ Code ”);
provided that if any of the Purchasers, or any person or
entity that owns a beneficial interest in any of the Purchasers, is
an “employee pension benefit plan” (within the meaning
of Section 3(2) of ERISA) with respect to which the Company is a
“party in interest” (within the meaning of Section
3(14) of ERISA), the requirements of Sections 407(d)(5) and 408(e)
of ERISA, if applicable, are met. As used in this Section
2.1(ff) , the term “ Plan ” shall
mean an “employee pension benefit plan” (as defined in
Section 3 of ERISA) which is or has been established or maintained,
or to which contributions are or have been made, by the Company or
any Subsidiary or by any trade or business, whether or not
incorporated, which, together with the Company or any Subsidiary,
is under common control, as described in Section 414(b) or (c) of
the Code.
(gg) Dilutive
Effect . The Company understands and acknowledges that its
obligation to (i) issue Conversion Shares upon an Optional
Conversion of the Notes in accordance with this Agreement and the
Note, and (ii) its obligations to issue the Warrant Shares upon the
exercise of the Warrants in accordance with this Agreement and the
Warrants, is, in each case, absolute and unconditional regardless
of the dilutive effect that such issuance may have on the ownership
interest of other stockholders of the Company.
(hh) No Integrated
Offering. Neither the Company, nor any of its affiliates, nor
any person acting on its or their behalf, has directly or
indirectly made any offers or sales of any security or solicited
any offers to buy any security under circumstances that would cause
the offering of the Securities pursuant to this Agreement to be
integrated with prior offerings by the Company for purposes of the
Securities Act which would prevent the Company from selling the
Securities pursuant to Rule 506 under the Securities Act, or any
applicable exchange-related stockholder approval provisions, nor
will the Company or any of its affiliates or Subsidiaries take any
action or steps that would cause the offering of the Securities to
be integrated with other offerings.
(ii) Listing
and Maintenance Requirements . Except as set forth
in the Commission Documents, the Company has not, in the two (2)
years preceding the date hereof, received notice (written or oral)
from any Trading Market on which the Common Stock is or has been
listed or quoted to the effect that the Company is not in
compliance with the listing or maintenance requirements of such
Trading Market. Except as set forth in the Commission
Documents, the Company is, and has no reason to believe that it
will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. “
Trading Market ” means the OTC Bulletin Board
or any other Eligible Market, or any other national securities
exchange, market or trading or quotation facility on which the
Common Stock is then listed or quoted. “ Eligible
Market ” means any of the New York Stock Exchange,
the American Stock Exchange, the NASDAQ Global Select Market, the
NASDAQ Global Market, the NASDAQ Capital Market or the
Over-the-Counter Bulletin Board.
(jj)
Independent Nature of Purchasers. The Company acknowledges
that the obligations of each Purchaser under the Transaction
Documents are several and not joint with the obligations of any
other Purchaser, and no Purchaser shall be responsible in any way
for the performance of the obligations of any other Purchaser under
the Transaction Documents. The Company acknowledges that the
decision of each Purchaser to purchase securities pursuant to this
Agreement has been made by such Purchaser independently of any
other purchase and independently of any information, materials,
statements or opinions as to the business, affairs, operations,
assets, properties, liabilities, results of operations, condition
(financial or otherwise) or prospects of the Company or of its
Subsidiaries which may have made or given by any other Purchaser or
by any agent or employee of any other Purchaser, and no Purchaser
or any of its agents or employees shall have any liability to any
Purchaser (or any other person) relating to or arising from any
such information, materials, statements or opinions. The Company
acknowledges that nothing contained herein, or in any Transaction
Document, and no action taken by any Purchaser pursuant hereto or
thereto, shall be deemed to constitute the Purchasers as a
partnership, an association, a joint venture or any other kind of
entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or
the transactions contemplated by the Transaction Documents. The
Company acknowledges that each Purchaser shall be entitled to
independently protect and enforce its rights, including without
limitation, the rights arising out of this Agreement or out of the
other Transaction Documents, and it shall not be necessary for any
other Purchaser to be joined as an additional party in any
proceeding for such purpose. The Company acknowledges that for
reasons of administrative convenience only, the Transaction
Documents have been prepared by counsel for one of the Purchasers
and such counsel does not represent all of the Purchasers but only
such Purchaser and the other Purchasers have retained their own
individual counsel with respect to the transactions contemplated
hereby. The Company acknowledges that it has elected to provide all
Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or
requested to do so by the Purchasers.
(kk) Questionable Payments .
Neither the Company nor any of its Subsidiaries, nor, to the
Company’s knowledge, any directors, officers, employees,
agents or other Persons acting on behalf of the Company or any of
its Subsidiaries has, in the course of its actions for, or on
behalf of, the Company: (a) directly or indirectly, used any
corporate funds for unlawful contributions, gifts, entertainment or
other unlawful expenses relating to foreign or domestic political
activity; (b) made any direct or indirect unlawful payments to any
foreign or domestic governmental officials or employees or to any
foreign or domestic political parties or campaigns from corporate
funds; (c) violated in any material respect any provision of the
Foreign Corrupt Practices Act of 1977, as amended; or (d) made any
other unlawful bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government
official or employee.
(ll) Application of
Takeover Protections . The Company and its board of directors
have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company’s
charter documents or the laws of its state of incorporation that is
or could reasonably be expected to become applicable to any of the
Purchasers as a result of the Purchasers and the Company fulfilling
their obligations or exercising their rights under the Transaction
Documents, including, without limitation, the Company’s
issuance of the Securities and the Purchasers’ ownership of
the Securities.
(mm) Transfer Agent . The name,
address, telephone number, fax number, contact person and email
address of the Company’s current transfer agent is set forth
on Schedule 2.1(mm) hereto.
Section 2.2
Representations and Warranties of the Purchasers . Each
Purchaser hereby makes the following representations and warranties
to the Company (with respect solely to itself and not with respect
to any other Purchaser), as of the date hereof, and as of the
Closing Date:
(a)
Organization and Standing of the Purchasers . If such
Purchaser is an entity, su
|